Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

129 ARTÍCULOS , VIENDO DEL 31 AL 45

Epidemiology of dementia-the epidemic we saw coming

Wurm R, Stögmann E.

Wien Med Wochenschr. 2021 Sep;171(11-12):247-248. doi: 10.1007/s10354-021-00838-6. Epub 2021 Aug 27.

Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis

Martinkova J, Quevenco FC, Karcher H, Ferrari A, Sandset EC, Szoeke C, Hort J, Schmidt R, Chadha AS, Ferretti MT.

JAMA Netw Open. 2021 Sep 1;4(9):e2124124. doi: 10.1001/jamanetworkopen.2021.24124.

Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease

Snider BJ, Holtzman DM.

Neuron. 2021 Oct 20;109(20):3199-3202. doi: 10.1016/j.neuron.2021.08.026. Epub 2021 Aug 24.

Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures

Wang H, Lu J, Zhao X, Qin R, Song K, Xu Y, Zhang J, Chen Y.

Neurol Sci. 2021 Dec;42(12):4913-4920. doi: 10.1007/s10072-021-05616-1. Epub 2021 Sep 22.

Risk of seizures and subclinical epileptiform activity in patients with dementia: A systematic review and meta-analysis

Zhao B, Shen LX, Ou YN, Ma YH, Dong Q, Tan L, Yu JT.

Ageing Res Rev. 2021 Dec;72:101478. doi: 10.1016/j.arr.2021.101478. Epub 2021 Oct 1.

Pathophysiological association between periodontal disease and Alzheimer's disease: Importance of periodontal health in the elderly

Desta NT.

J Oral Biosci. 2021 Dec;63(4):351-359. doi: 10.1016/j.job.2021.08.007. Epub 2021 Oct 9.

Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet

Takeishi J, Tatewaki Y, Nakase T, Takano Y, Tomita N, Yamamoto S, Mutoh T, Taki Y.

Int J Mol Sci. 2021 Nov 15;22(22):12310. doi: 10.3390/ijms222212310.

Environmental Substances Associated with Alzheimer's Disease-A Scoping Review

Elonheimo HM, Andersen HR, Katsonouri A, Tolonen H.

Int J Environ Res Public Health. 2021 Nov 11;18(22):11839. doi: 10.3390/ijerph182211839.

COVID-19 and Alzheimer's Disease: A Literature Review

Hardan L, Filtchev D, Kassem R, Bourgi R, Lukomska-Szymanska M, Tarhini H, Salloum-Yared F, Mancino D, Kharouf N, Haikel Y.

Medicina (Kaunas). 2021 Oct 25;57(11):1159. doi: 10.3390/medicina57111159.

Alzheimer's Disease and Face Masks in Times of COVID-19

Gil R, Arroyo-Anlló EM.

J Alzheimers Dis. 2021;79(1):9-14. doi: 10.3233/JAD-201233.

Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease

Musiek ES, Morris JC.

JAMA Neurol. 2021 Feb 1;78(2):141-142. doi: 10.1001/jamaneurol.2020.4478.

Early-Onset Alzheimer's Disease: What Is Missing in Research?

Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C.

Curr Neurol Neurosci Rep. 2021 Jan 19;21(2):4. doi: 10.1007/s11910-020-01090-y.

Is Alzheimer Disease an Autoimmune Disorder?

Bertholf RL.

J Appl Lab Med. 2021 Apr 29;6(3):588-591. doi: 10.1093/jalm/jfaa235.

Difficulty Taking Medications: a Corollary to Dementia Risk

Chen P, Covinsky K.

J Gen Intern Med. 2021 Apr;36(4):861-862. doi: 10.1007/s11606-020-06531-5. Epub 2021 Feb 2.

Virtual care for patients with Alzheimer disease and related dementias during the COVID-19 era and beyond

Gosse PJ, Kassardjian CD, Masellis M, Mitchell SB.

CMAJ. 2021 Mar 15;193(11):E371-E377. doi: 10.1503/cmaj.201938.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias